<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03902795</url>
  </required_header>
  <id_info>
    <org_study_id>0004</org_study_id>
    <nct_id>NCT03902795</nct_id>
  </id_info>
  <brief_title>Functional and Morphological Results of Rhegmatogenous Retinal Detachment Treated With Vitrectomy</brief_title>
  <official_title>Functional and Morphological Results of macula-on and Macula-off Rhegmatogenous Retinal Detachment Treated With Pars Plana Vitrectomy and Sulfur Hexafluoride Gas Tamponade</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Lublin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Lublin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To examine morphological and functional results after pars plana vitrectomy (PPV) with SF6
      gas tamponade due to macula-on and macula-off rhegmatogenous retinal detachment (RRD) during
      six months of the follow-up.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:

      To examine morphological and functional results after pars plana vitrectomy (PPV) with SF6
      gas tamponade due to macula-on and macula-off rhegmatogenous retinal detachment (RRD) during
      six months of the follow-up.

      Methods:

      The study included 62 eyes that underwent successful PPV with SF6 tamponade with macula-on
      (34 eyes) and macula-off (28 eyes) RRD preoperatively. The best-corrected visual acuity
      (BCVA), Amsler test, M-charts, optical coherence tomography (OCT) and microperimetry were
      performed at 1, 3 and 6 months postoperatively.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Actual">October 2017</completion_date>
  <primary_completion_date type="Actual">October 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The best-corrected visual acuity (BCVA)</measure>
    <time_frame>1 to 6 months</time_frame>
    <description>Acuity is a measure of visual performance. The eye exam seeks to find the prescription that will provide the best corrected visual performance achievable.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Amsler test</measure>
    <time_frame>1 to 6 months</time_frame>
    <description>The standard Amsler test performs with black lines on the white background. The Amsler grid has been used so far for the qualitative assessment of the metamorphopsia since 1947.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>M-charts</measure>
    <time_frame>1 to 6 months</time_frame>
    <description>The M-charts consist of 19 dashed lines with increasing distance between points in the range of 0.2 ° to 2.0 ° viewing angle. Matsumoto developed M-charts for quantitative metamorphopsia evaluation in macula diseases in 1990. M-charts provide more information than Amsler chart in regard to the horizontal and vertical lines.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Central retinal thickness</measure>
    <time_frame>1 to 6 months</time_frame>
    <description>Quantitative thickness measurements derived from the &quot;fast macular scan&quot; algorithm report retinal thickness at several locations including the center point, central subfield, and 4 inner and 4 outer zones of the macula.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Microperimetry</measure>
    <time_frame>1 to 6 months</time_frame>
    <description>Microperimetry is a procedure to assess retinal sensitivity while fundus is directly examined; it enables exact correlation between macular pathology and corresponding functional abnormality.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">62</enrollment>
  <condition>Retinal Detachment</condition>
  <condition>Vitrectomy</condition>
  <arm_group>
    <arm_group_label>Group of 62 eyes</arm_group_label>
    <description>Group of 62 eyes with rhegmatogenous retinal detachment who underwent successful vitrectomy with SF6 tamponade</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Microperimetry</intervention_name>
    <description>Microperimetry is a procedure to assess retinal sensitivity while fundus is directly examined; it enables exact correlation between macular pathology and corresponding functional abnormality.</description>
    <arm_group_label>Group of 62 eyes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>M-charts</intervention_name>
    <description>The M-chart (Inami Co., Tokyo, Japan) is a diagnostic tool developed by Matsumoto to quantify the degree of metamorphopsia in patients with macular diseases.</description>
    <arm_group_label>Group of 62 eyes</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study included 62 eyes that underwent successful vitrectomy with SF6 tamponade with
        macula-on (34 eyes) and macula-off (28 eyes) RRD preoperatively.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The diagnosed macula-on and macula-off rhegmatogenous retinal detachment.

        Exclusion Criteria:

          -  history of uveitis,

          -  diabetic retinopathy,

          -  previous vitreoretinal surgery,

          -  glaucoma or eye trauma,

          -  retinal detachment combined with macular hole or proliferative vitreoretinopathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>General Department of Ophthalmology in Lublin</name>
      <address>
        <city>Lublin</city>
        <zip>20-001</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 1, 2019</study_first_submitted>
  <study_first_submitted_qc>April 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2019</study_first_posted>
  <last_update_submitted>April 3, 2019</last_update_submitted>
  <last_update_submitted_qc>April 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Rhegmatogenous retinal detachment</keyword>
  <keyword>Vitrectomy</keyword>
  <keyword>Metamorphopsia</keyword>
  <keyword>M-charts</keyword>
  <keyword>Microperimetry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Detachment</mesh_term>
    <mesh_term>Dissociative Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All data will be available in brief.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

